Achillion Appoints CSO
This article was originally published in Scrip
Achillion Pharmaceuticals has appointed Joel Barrish chief scientific officer and executive vice president – effective Jan. 4, 2016. Barrish has over 30 years' experience in the pharmaceutical industry and most recently was vice president and head of discovery chemistry at Bristol-Myers Squibb (BMS). He has also co-authored more than 120 peer-reviewed publications.